90 related articles for article (PubMed ID: 14960313)
1. The functional interaction between HMGA1 and the estrogen receptor requires either the N- or the C-terminal domain of the receptor.
Massaad-Massade L; Tacine R; Dulauroy S; Reeves R; Barouki R
FEBS Lett; 2004 Feb; 559(1-3):89-95. PubMed ID: 14960313
[TBL] [Abstract][Full Text] [Related]
2. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity.
Fan S; Ma YX; Wang C; Yuan RQ; Meng Q; Wang JA; Erdos M; Goldberg ID; Webb P; Kushner PJ; Pestell RG; Rosen EM
Oncogene; 2001 Jan; 20(1):77-87. PubMed ID: 11244506
[TBL] [Abstract][Full Text] [Related]
3. Targeting estrogen responsive elements (EREs): design of potent transactivators for ERE-containing genes.
Huang J; Li X; Yi P; Hilf R; Bambara RA; Muyan M
Mol Cell Endocrinol; 2004 Apr; 218(1-2):65-78. PubMed ID: 15130512
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional suppression of the estrogen receptor by truncated estrogen receptor-alpha.
Ikeda M; Okai M; Miyoshi T; Tone S; Minatogawa Y
Horm Metab Res; 2002 Aug; 34(8):425-30. PubMed ID: 12198596
[TBL] [Abstract][Full Text] [Related]
5. ERR-10: a new repressor in transcriptional signaling activation of estrogen receptor-alpha.
Meng Q; Zhao Z; Yan M; Zhou L; Li J; Kitt C; Bin G; Fan S
FEBS Lett; 2004 Oct; 576(1-2):190-200. PubMed ID: 15474036
[TBL] [Abstract][Full Text] [Related]
6. ERBP, a novel estrogen receptor binding protein enhancing the activity of estrogen receptor.
Bu H; Kashireddy P; Chang J; Zhu YT; Zhang Z; Zheng W; Rao SM; Zhu YJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):54-9. PubMed ID: 15047147
[TBL] [Abstract][Full Text] [Related]
7. HMGA1 inhibits the function of p53 family members in thyroid cancer cells.
Frasca F; Rustighi A; Malaguarnera R; Altamura S; Vigneri P; Del Sal G; Giancotti V; Pezzino V; Vigneri R; Manfioletti G
Cancer Res; 2006 Mar; 66(6):2980-9. PubMed ID: 16540646
[TBL] [Abstract][Full Text] [Related]
8. N-terminal activation function is dominant in ligand-dependent transactivation of medaka estrogen receptor alpha in human cells.
Mezaki Y; Yoshida T; Yanagisawa J; Kato S
Biochem Biophys Res Commun; 2001 Dec; 289(3):763-8. PubMed ID: 11726214
[TBL] [Abstract][Full Text] [Related]
9. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
[TBL] [Abstract][Full Text] [Related]
10. Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
Shaffer PL; McDonnell DP; Gewirth DT
Biochemistry; 2005 Feb; 44(7):2678-85. PubMed ID: 15709781
[TBL] [Abstract][Full Text] [Related]
11. Properties of overlapping EREs: synergistic activation of transcription and cooperative binding of ER.
Massaad C; Coumoul X; Sabbah M; Garlatti M; Redeuilh G; Barouki R
Biochemistry; 1998 Apr; 37(17):6023-32. PubMed ID: 9558340
[TBL] [Abstract][Full Text] [Related]
12. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP.
Maharjan S; Serova L; Sabban EL
J Neurochem; 2005 Jun; 93(6):1502-14. PubMed ID: 15935066
[TBL] [Abstract][Full Text] [Related]
14. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain.
Métivier R; Petit FG; Valotaire Y; Pakdel F
Mol Endocrinol; 2000 Nov; 14(11):1849-71. PubMed ID: 11075817
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner.
Zirngibl RA; Chan JS; Aubin JE
J Mol Endocrinol; 2008 Feb; 40(2):61-73. PubMed ID: 18234909
[TBL] [Abstract][Full Text] [Related]
16. Interplay of flexibility and stability in the control of estrogen receptor activity.
Bouter A; Le Tilly V; Sire O
Biochemistry; 2005 Jan; 44(2):790-8. PubMed ID: 15641807
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways.
Chen XN; Zhu H; Meng QY; Zhou JN
Brain Res; 2008 Aug; 1223():1-10. PubMed ID: 18597742
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of ER alpha and ER beta involved in selectivity of 16 alpha-iodo-7 beta estradiol.
Bhat RA; Stauffer B; Unwalla RJ; Xu Z; Harris HA; Komm BS
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):17-26. PubMed ID: 15026080
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of the BRCA1 : estrogen receptor interaction.
Ma YX; Tomita Y; Fan S; Wu K; Tong Y; Zhao Z; Song LN; Goldberg ID; Rosen EM
Oncogene; 2005 Mar; 24(11):1831-46. PubMed ID: 15674350
[TBL] [Abstract][Full Text] [Related]
20. Estrogen regulation of chicken riboflavin carrier protein gene is mediated by ERE half sites without direct binding of estrogen receptor.
Bahadur U; Ganjam GK; Vasudevan N; Kondaiah P
Mol Cell Endocrinol; 2005 Feb; 231(1-2):1-11. PubMed ID: 15713531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
